3 hours Leerink Partnrs Has Negative Outlook of TRVI FY2024 EarningsMarketBeat
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Stock analysts at Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of Trevi Therapeutics in a research note issued on Tuesday, October 15th. Leerink Partnrs analyst F…
Earnings · Nasdaq 100 · Science
X